The total return over the past 12 months is +30.14% vs. +16.94% for the S&P 500. So far it's up -41.97% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +30.14% | (41.51%) | (70.43%) | (54.11%) | (43.94%) | N/A |
| Total Return CAGR | +30.14% | (41.51%) | (70.43%) | (54.11%) | (43.94%) | N/A |
| Revenue CAGR | (75.00%) | N/A | (46.91%) | (20.14%) | (10.41%) | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
iBio, Inc. (IBIO)
| Year | Start price | End price | IBIO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.93 | $1.12 | (41.97%) | +14.51% | (56.48%) |
| 2025 | $2.45 | $1.93 | (21.22%) | +17.72% | (38.94%) |
| 2024 | $1.37 | $2.45 | +78.83% | +24.89% | +53.94% |
| 2023 | $8.80 | $1.37 | (84.43%) | +26.19% | (110.62%) |
| 2022 | $275.00 | $8.80 | (96.80%) | (18.17%) | (78.63%) |
| 2021 | $525.00 | $275.00 | (47.62%) | +28.74% | (76.36%) |
| 2020 | $125.00 | $525.00 | +320.00% | +18.37% | +301.63% |
| 2019 | $375.00 | $125.00 | (66.67%) | +31.22% | (97.89%) |
| 2018 | $900.00 | $375.00 | (58.33%) | (4.56%) | (53.77%) |
| 2017 | $2,000.00 | $900.00 | (55.00%) | +21.70% | (76.70%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
